PHARMA LAB · PL-04-014

Laboratory temperature excursions: samples, reagents and studies

Returning to the set temperature does not close the event: connect chronology, materials, stability evidence and authorized decisions.
Technical comic illustration of two professionals assessing a gap in temperature records beside closed samples and a laboratory chamber.

After an excursion, the laboratory must answer three different questions: is the equipment suitable again, can the materials still be used, and which results or studies are affected? A positive answer to the first does not automatically resolve the others. Start with a verifiable reconstruction of exposure and its uncertainties.

This article concerns laboratory samples, reagents and activities. It sets no universally tolerable duration and does not decide study validity without the relevant protocol and evidence.

Protect materials and record the initial state

Apply authorized procedures to limit further exposure, manage material status and inform responsible personnel. Identify unit, location, detection time and responding person. Do not wait for the investigation to finish before activating protection already defined in the plan.

A transfer requires a suitable destination and traceability of everything moved. Record departure, arrival and relevant conditions during the transfer too. Prevent material under assessment from being used simply because the receiving refrigerator has the correct temperature.

Preserve original data before changing settings or replacing components, while maintaining safety. Record urgent actions when they occur; identify later reconstructions as such. The chronology must distinguish event, detection, notification and intervention.

Reconstruct the timeline using usable data

Collect the full time series, not only minimum and maximum. Identify sensors, locations, units, acquisition interval, relevant calibrations and active configuration. Check clock synchronization, documented corrections, interruptions and consistency between records.

The first out-of-condition value may occur after the actual event began; the last compliant value before a gap does not demonstrate what happened afterward. Distinguish measured duration, potentially affected interval and unobserved periods. An interpolated line is an estimate, not newly acquired data.

Minimum checklist: raw data and metadata; configuration and metrological status; door, power and maintenance logs; inventory and positions; material movements; actions and communications; requirements and stability sources; declared gaps and assumptions. Annex 11 supports data preservation and incident management within applicable GMP scope. [1]

Identify affected materials, preparations and activities

Cross-reference inventory and chronology. For each sample, consider identity, aliquot, location, residence time and destination. For reagents, add batch, container, opening or preparation, applicable expiry and subsequent uses. Do not assume everything currently in the unit was present during the event.

Trace links to analytical sequences, preparations, controls and studies. An affected reagent may have been used before the problem was recognized: assessment must include those results, not just remaining stock.

For stability protocols, identify planned conditions, sampling points and transferred samples. For microbiological testing, see incubation conditions and excursions: equipment suitability and method interpretation remain distinct decisions.

Compare exposure with relevant evidence

Use requirements and data for the actual material: formulation, concentration, packaging, open or closed state, stage of use and attribute to preserve. Record source, version and coverage. Data for a similar product may guide a question but do not automatically demonstrate acceptability.

ICH Q1A(R2) considers stability data when evaluating short excursions within its scope of drug substances and products. [2] It provides no general authorization for every reagent or sample. Assess earlier exposures and freeze–thaw cycles where relevant; separate events may contribute to a cumulative history.

Air temperature does not necessarily equal material temperature. NIST’s experimental report on vaccine refrigerators shows response differences in the studied configurations. [3] Applying them to your case requires representative evidence for container, volume, position and loading. Assumed thermal inertia alone does not justify an exemption.

State uncertainty and limits of conclusions

Where information is missing, describe plausible scenarios and their supporting evidence. Separate observations, justified estimates and unproven assumptions. An independent probe helps only if location, timing and conditions make it relevant; sharing the same room is insufficient.

Consider measurement uncertainty, distribution within the unit and material response without mechanically adding them as identical quantities. Mapping data apply within the documented configuration, not to every failure or load.

An average can hide extremes and duration. Mean kinetic temperature does not reconstruct missing data or erase freezing, physical changes or conditions outside the model. Any calculation requires scientific validity for the material and phenomenon involved; do not use it as an automatic release criterion.

Original matrix for defining the decision boundary
Material or activityRequirementReconstructed exposureEvidence to assessDecision and owner
Opened reagentConditions and period after openingPosition, residence and previous historyData relevant to the in-use stateSuitability and affected results: authorized function
Sample or aliquotStorage for intended analysisProfile, transfers and relevant cyclesStability of the measured attributeUse, restriction or other justified disposition
Stability sampleStudy protocol and conditionsAffected interval and positionsDeviation and significance for the studyStudy owner and quality according to assigned roles
Preparation already usedValidity for the methodExposure before useLinks to tests and controlsRetrospective assessment of results

Decide, investigate and verify actions

The decision must identify covered materials and uses, evidence, residual uncertainties, restrictions and approvals. WHO guidance on nonconforming work includes effects on previous results and responsibility for authorizing resumption. [4] The repair technician’s signature alone cannot replace this assessment.

A favorable new test does not, by definition, prove that every attribute remained unchanged or recreate previous history. Additional tests require a specific question, suitable method and justified plan. Avoid repetitions aimed solely at obtaining an acceptable result.

Investigate technical and organizational causes, distinguishing immediate correction from corrective and preventive actions. Define evidence of effectiveness: recurrence, control reliability and response capability, over a justified observation period.

Restore equipment and review controls

Before returning to use, verify functions affected by the event and repair. Depending on impact, functional checks, calibration or targeted requalification may be necessary. A recovered display does not demonstrate distribution, data continuity or correct notification.

Review alarms and escalation, keeping equipment authorization separate from material disposition. Close the event only when decisions, outstanding actions and responsibilities are traceable.

Simulated case: two compliant readings and a gap

A laboratory has compliant readings before and after an interruption, but none during it. This case is simulated. The technical log shows a restart; it does not establish the thermal profile. The team identifies materials and studies present and seeks genuinely representative independent records.

If evidence remains insufficient, it documents the unproven interval and limits its conclusions. The authorized decision may require restrictions or further assessment; continuity is not declared merely by connecting the two points. Return to the Laboratory Equipment & Controlled Storage hub.

Sources and scope

Verified: October 1, 2026. Original GuideGxP matrix, checklist and case. Consolidated ICH Q1 remains a Step 2b draft in the consulted EMA record.

  1. EU GMP Annex 11, 2011: data, incidents and continuity.
  2. ICH Q1A(R2), 2003, §§2.1.7 and 2.2.7: stability within the stated scope, without universal laboratory tolerances.
  3. NISTIR 7900, 2012: experimental study of vaccine refrigeration systems, not a general GMP criterion.
  4. WHO, Good practices for pharmaceutical quality control laboratories, TRS 1052, Annex 4, 2024, §6.11 and relevant sections on reagents and corrective actions.
Technical content for informed decisions; it does not replace the approved procedure, applicable requirements or the instrument manual.

Continue exploring